Bausch + Lomb Corporation
NYSE:BLCOMedical - Instruments & Supplies
+$0.04 today
- Market cap
- $7.49B
- Beta
- 0.57
- P/E (TTM)
- -24.2
- EPS (TTM)
- -$0.62
Volume 0.51M
Average 0.46M
BLCO Free Cash Flow
Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.
Bausch + Lomb CorporationNYSE: BLCO
Free Cash Flow · Q2 FY2026 · quarter ended Jun 2026
Free cash flow turns positive
Q2 FY2026 free cash flow was $82M, compared with -$54M a year earlier. Trailing-twelve-month free cash flow was $140.33M.
Context
- Free cash flow amounted to 1.3% of revenue in FY2025, unchanged from a year earlier.
- Free cash flow increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly free cash flow holds near $82M or moves back toward the trailing-twelve-month quarterly average of $35.08M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Free Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (66M) USD
- Year-over-year change
- -11.9%
| Period | Period end | Free Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (66M) | -11.9% |
| FY2024 | 2024-12-31 | (59M) | +70.2% |
| FY2023 | 2023-12-31 | (198M) | -216.5% |
| FY2022 | 2022-12-31 | 170M | -75.0% |
| FY2021 | 2021-12-31 | 680M | — |
Free Cash Flow vs competitors
How BLCO compares with its peers on the latest reported figures
- BLCO's LTM Jun 2026 free cash flow of $140.33M is the 8th largest of the 10 companies compared; the peer median is $12.2M.
- Its year-over-year change of +185.0% is the 3rd highest of 10, against a peer median of +5.1%.
- Free cash flow amounts to 2.6% of revenue for BLCO, versus a peer median of 22.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $4.33B | +260.8% | +44.4% | 28.3% | |
| LTM Jun 2026 | $1.2B | +124.8% | +56.0% | — | |
| LTM Jun 2026 | $390.63M | -1.5% | -2.3% | 15.0% | |
| LTM Sep 2026 | $376.72M | +24.3% | -13.4% | 1496.6% | |
| LTM Jun 2026 | $332.56M | -148.8% | — | 33.0% | |
| LTM Sep 2026 | $283.94M | -281.0% | -4.9% | 63.0% | |
| LTM Sep 2026 | $252.22M | +5.1% | +45.3% | 15.7% | |
| LTM Jun 2026 | $140.33M | +185.0% | — | 2.6% | |
| LTM Sep 2026 | $85.56M | +221.8% | -47.9% | 9.5% | |
| LTM Jun 2026 | $12.2M | -54.7% | -5.2% | 2.0% | |
| Peer median (excluding BLCO) | $12.2M | +5.1% | -3.6% | 22.0% | |
Competitors are the stored peer set for BLCO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 193M | 15M | (248M) | (305M) | (352M) |
| Depreciation & Amortization | 415M | 379M | 382M | 436M | 421M |
| Deferred Income Tax | 116M | (90M) | (10M) | (10M) | (32M) |
| Stock-Based Compensation | 62M | 62M | 74M | 92M | 149M |
| Change in Working Capital | 28M | (19M) | (287M) | (87M) | 18M |
| Accounts Receivables | (107M) | (95M) | (121M) | (227M) | (148M) |
| Inventory | (15M) | (106M) | (264M) | (147M) | 38M |
| Accounts Payables | 163M | 189M | 245M | 126M | 108M |
| Other Working Capital | (13M) | (7M) | (147M) | 161M | 20M |
| Other Non-Cash Items | 59M | (2M) | 72M | 106M | 79M |
| Operating Cash Flow | 873M | 345M | (17M) | 232M | 283M |
| Capital Expenditures | (193M) | (175M) | (181M) | (291M) | (349M) |
| Acquisitions (Net) | (16M) | 45M | (1.94B) | 0 | 0 |
| Purchases of Investments | (19M) | (62M) | (17M) | (12M) | (11M) |
| Sales of Investments | 14M | 22M | 16M | 14M | 8M |
| Other Investing Activities | 0 | (45M) | 14M | (123M) | (103M) |
| Investing Cash Flow | (214M) | (215M) | (2.11B) | (412M) | (455M) |
| Debt Repayment | 28M | 2.46B | 2.12B | 201M | 249M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | (12M) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (740M) | (2.38B) | (37M) | (11M) | (24M) |
| Financing Cash Flow | (712M) | 81M | 2.08B | 178M | 225M |
| Effect of Forex Changes | (8M) | (8M) | 2M | (16M) | 28M |
| Net Change in Cash | (61M) | 203M | (46M) | (18M) | 81M |
| Free Cash Flow | 680M | 170M | (198M) | (59M) | (66M) |
Bausch + Lomb Corporation
NYSE:BLCO
Intrinsic Alpha fair value
Locked
Current Price
$20.95
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.